News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,744 Results
Type
Article (1921)
Company Profile (2)
Press Release (67821)
Section
Business (21464)
Career Advice (9)
Deals (4552)
Drug Development (8160)
FDA (1804)
Job Trends (802)
News (37020)
Policy (3560)
Tag
Academia (92)
Allergies (3)
Alliances (8128)
ALS (4)
Alzheimer's disease (122)
Antibody-drug conjugate (ADC) (11)
Approvals (1830)
Artificial intelligence (13)
Automation (1)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (19)
Biotechnology (5)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (17)
Cancer (188)
Cardiovascular disease (5)
Career advice (9)
CAR-T (2)
Cell therapy (21)
Clinical research (6993)
Collaboration (87)
Compensation (8)
Complete response letters (2)
COVID-19 (184)
C-suite (13)
Cystic fibrosis (4)
Data (167)
Depression (1)
Diabetes (13)
Diagnostics (596)
Digital health (1)
Drug discovery (12)
Duchenne muscular dystrophy (12)
Earnings (7604)
Events (6955)
Executive appointments (46)
FDA (1933)
Featured Employer (1)
Fibrodysplasia Ossificans Progressiva (1)
Funding (52)
Gene editing (3)
Gene therapy (17)
GLP-1 (44)
Government (233)
Guidances (4)
Healthcare (1077)
IgA nephropathy (4)
Immunology and inflammation (1)
Indications (3)
Infectious disease (190)
Inflammatory bowel disease (17)
Influenza (5)
Intellectual property (16)
IPO (1623)
Job creations (241)
Job search strategy (9)
Layoffs (7)
Legal (949)
Liver cancer (16)
Lung cancer (31)
Lymphoma (10)
Manufacturing (28)
MASH (6)
Medical device (1117)
Medtech (1118)
Mergers & acquisitions (3017)
Metabolic disorders (37)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (6)
Neuroscience (159)
NextGen: Class of 2025 (220)
Non-profit (61)
Northern California (124)
Obesity (16)
Opinion (1)
Ovarian cancer (10)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (12)
Partnered (2)
Patents (16)
Patient recruitment (6)
People (4955)
Pharmaceutical (3)
Phase I (1900)
Phase II (2924)
Phase III (2656)
Pipeline (107)
Postmarket research (241)
Preclinical (664)
Press Release (2)
Prostate cancer (6)
Radiopharmaceuticals (22)
Rare diseases (24)
Real estate (599)
Regulatory (2584)
Reports (6)
Research institute (91)
Schizophrenia (6)
Series A (13)
Series B (4)
Service/supplier (1)
Sickle cell disease (1)
Southern California (146)
Spinal muscular atrophy (4)
Startups (422)
Stomach cancer (1)
Supply chain (6)
United States (1200)
Vaccines (21)
Venture capitalists (2)
Webinars (1)
Weight loss (2)
Women's health (1)
Date
Today (20)
Last 7 days (83)
Last 30 days (250)
Last 365 days (3067)
2025 (654)
2024 (3253)
2023 (3815)
2022 (7014)
2021 (6373)
2020 (5873)
2019 (3864)
2018 (3011)
2017 (3560)
2016 (3171)
2015 (4031)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Alabama (1)
Arizona (8)
Asia (21333)
Australia (2429)
California (314)
Canada (214)
China (144)
Colorado (4)
Connecticut (13)
Delaware (4)
Europe (12413)
Florida (22)
Georgia (7)
Illinois (16)
India (10)
Indiana (2)
Japan (70)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (74)
Massachusetts (219)
Michigan (2)
Minnesota (26)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (178)
New York (133)
North Carolina (55)
Northern California (124)
Ohio (2)
Oregon (1)
Pennsylvania (50)
South America (106)
Southern California (146)
Tennessee (1)
Texas (26)
Utah (12)
Virginia (22)
Washington D.C. (2)
Washington State (12)
Wisconsin (6)
69,744 Results for "polypid ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid to Participate in the 37th Annual ROTH Conference
March 4, 2025
·
1 min read
Press Releases
PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
January 30, 2025
·
1 min read
Press Releases
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
February 12, 2025
·
12 min read
Press Releases
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
March 11, 2025
·
6 min read
PolyPid to Participate in Citizens JMP Life Sciences Conference
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that company management will present at the Citizens JMP Life Sciences Conference taking place in New York, NY, from May 13 – 14, 2024.
May 1, 2024
·
1 min read
Press Releases
PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025
January 29, 2025
·
1 min read
Business
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, provided a corporate update and reported financial results for the three months ended March 31, 2024.
May 8, 2024
·
10 min read
Drug Development
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, hosted a virtual Key Opinion Leader event discussing the significant unmet medical need in the prevention of surgical site infections.
June 18, 2024
·
7 min read
Business
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it will report its first quarter 2024 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 8, 2024.
April 24, 2024
·
1 min read
Drug Development
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
PolyPid Ltd. announced that it will host a virtual Key Opinion Leader event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company’s ongoing D-PLEX100 Phase 3 trial.
June 10, 2024
·
5 min read
1 of 6,975
Next
